Articles in Cardiovascular Innovations Issue 4 |
| | |
Title | Summary |
New mitral valve repair systems under testing | Cardiovascular Innovations reports on the latest developments in the heart valve market. We begi...[more] |
Heart Valve Surgery | One of the largest therapy areas of cardiovascular disease is heart valve surgery. This type of ...[more] |
MIVT develops advanced drug-eluting coatings for cardiovascular stents | MIV Therapeutics (MIVT) is currently developing a next-generation line of advanced biocompatible...[more] |
Leman Cardiovascular acquires Hancock Jaffe Laboratories | Swiss biomedical device company, Leman Cardiovascular (LCV), has recently acquired US company Ha...[more] |
Battelle Ventures invests in Endovalve | Endovalve, Inc., a cardiovascular device company developing a percutaneous valve-replacement sys...[more] |
CoreValve: Revolutionising heart valve replacement | Traditionally, when a patients’ heart valve had to be replaced, open-heart surgery was the only ...[more] |
Cardiovascular market maintains growth despite concerns | Despite concerns regarding the long-term outcomes from drug-eluting stents (recent reports in th...[more] |
TopSpin looks to the future of Cardiovascular Imaging | The advantages of MRI as an imaging technology are numerous. Its sensitivity to the chemical cha...[more] |
FDA meets with Boston Scientific/Guidant to discuss recalls | The FDA has met with Boston Scientific/Guidant to discuss the firm's recent announcement that se...[more] |
TAXCOR-I DES: cleared for use in Europe | EuroCor GmBH (a wholly-owned subsidiary of Opto Circuits [India] Ltd) has received the CE mark f...[more] |
AtriCure launches new devices | AtriCure has received 510(k) clearance from the FDA for its Isolator Transpolar Pen System (Pen)...[more] |
US trial to assess PAS-Port system for use in bypass surgery | Cardica has started a pivotal clinical trial in the US and Europe to evaluate the safety and eff...[more] |
Kaneka moves towards human tacrolimus DES trial | Kaneka has obtained positive results from preclinical trials for a drug-eluting stent (DES) that...[more] |
Eyes inside the heart | CardioOptics, Inc., a US medical device company developing and commercialising unique therapeuti...[more] |
FDA to review Cardima's Revelation Tx PMA | The FDA has granted a review of the scientific dispute underlying the agency’s refusal to approv...[more] |
New method for coating stents | Elutex is offering a new technique for coating stents that aims to replace the existing mechanic...[more] |
Osiris to offer IPO | Osiris Therapeutics has announced an initial public offering of 3.5 million shares. The company’...[more] |
ReVas technology licensed to Medtronic | RVX Therapeutics Inc, a subsidiary of Resverlogix Corp (RVX), has signed a licensing agreement, ...[more] |
Cordis/ClearStream in Crescendo Balloon agreement | Cordis Corporation and ClearStream Technologies Group, have signed a definitive agreement whereb...[more] |
Abbott/Medinol to settle patent dispute | Abbott Laboratories is finalising a patent infringement case settlement with Israeli company, Me...[more] |